Teen's Death Raises Questions About Duchenne Gene Therapy
A recent event has brought attention to the risks of gene therapy for Duchenne muscular dystrophy. A 16-year-old boy lost his life after receiving Elevidys, a treatment designed to combat this severe condition. This unfortunate incident marks the first known death associated with this particular the